However, since at a later phase c-Src induces the downregulation of LAR expression, the combined action of both apparently antagonist systems further reduced net DAPK activity, enhancing therefore EGF-dependent tumor cell migration and invasiveness [256]. Here, DAPK1 is linked to neoplasm.